• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Life Sciences | News, Analysis, Insights - HIT Consultant

Pleno Secures $40M to Disrupt Sequencing Market, Scale Multi-omics

by Fred Pennic 10/12/2022 Leave a Comment

Genetics Startup Pleno Launches Out of Stealth with $15M

What You Should Know: - Pleno, Inc, a multi-omic instrument platform company revolutionizing biological target detection for clinical testing and biomedical research raises $40M in Series A funding led by Deerfield Management and Foresite Capital.  - The funding will accelerate the development of Pleno’s Hypercoding™ instrument platform, called RAPTOR ™, which is slated for early customer access in 2023 and full availability in 2024. Release below
Read More

 The Botched COVID-19 Response and What We Can Learn from It

by Johonniuss Chemweno, Founder & CEO of VIP StarNETWORK, LLC 10/07/2022 Leave a Comment

The Botched COVID-19 Response and What We Can Learn from It

The COVID-19 pandemic has completely transformed the World Order and exposed striking realities of the global healthcare infrastructure by revealing the tendencies of various countries to deal with public healthcare emergencies. It has further raised the curtain on global hegemons like the U.S.A., which lacked the capacity and finances to counter this disaster. This has intensified the need for reforms and strong legislation to mitigate the pandemic’s devastation on healthcare facilities.
Read More

Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals

by Syed Hamza Sohail 10/03/2022 Leave a Comment

Accommodations Increase Clinical Trial Participation for Patients of Color, Survey Reveals

What You Should Know: - In a recent patient-centric survey, SubjectWell found that accommodations for all patients, including free treatment and study compensation, increase interest in clinical trial participation – particularly for patients of color. - However, overall, using value-based messaging, adding education to the recruiting process and reducing friction to participation – are universally impactful, not just for diverse populations, and that certain barriers
Read More

Study Confirms mRNA Vaccines Protect Against COVID-19 During Pregnancy

by Syed Hamza Sohail 09/30/2022 Leave a Comment

16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1

What You Should Know: - The first large, real-world study of the effectiveness of mRNA COVID-19 vaccines during pregnancy found these vaccines, especially two initial doses followed by a booster, are effective in protecting against serious disease in expectant mothers whether the shots are administered before or during pregnancy - Pregnant women were excluded from COVID-19 mRNA vaccine clinical trials, so this new study fills a significant knowledge gap, providing strong evidence that
Read More

Tavros Therapeutics Raises $7.5M to Develop Targeted Cancer Therapies

by Fred Pennic 09/27/2022 Leave a Comment

Tavros Therapeutics Raises $7.5M to Develop Targeted Cancer Therapies

What You Should Know: - Tavros Therapeutics, a precision oncology platform company leading the new frontier of targeted therapies exploiting tumors’ genetic vulnerabilities raises $7.5 million in Seed II financing co-led by existing investor Piedmont Capital Investments and new investor KdT Ventures, with participation from Alexandria Venture Investments. - Tavros launched in 2020 with a $3 million seed financing by Piedmont Capital Investments and a strategic collaboration with Zentalis
Read More

Biden-⁠Harris Admin Awards $1.5B to Address Overdose Epidemic

by Jasmine Pennic 09/26/2022 Leave a Comment

Biden-⁠Harris Admin Awards $1.5B to Address Overdose Epidemic

What You Should Know: - The U.S Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), awarded nearly $1.5 billion to support states, tribal lands, and territories’ efforts to address the opioid crisis and support individuals in recovery. - The grants are part of SAMHSA’s State Opioid Response and Tribal Opioid Response grant programs. The grant programs provide funding to states and territories to increase access to
Read More

Caris Life Sciences Integrates with Flatiron Health for Molecular Testing

by Jasmine Pennic 09/23/2022 Leave a Comment

Epic Integrates Caris Molecular Testing Portfolio with Epic’s ORA Network

What You Should Know: - Caris Life Sciences, the leading molecular science and technology company, announced their partnership with Flatiron Health to fully integrate Caris’ molecular testing portfolio with Flatiron’s OncoEMR®, a cloud-based electronic medical record (EMR) tool. - This partnership streamlines clinical workflows for physicians, delivering critical results directly at the point of care to help them make better treatment decisions for their patients.    Molecular
Read More

Naveris Raises $51M for Early Detection of Viral-Driven Cancers

by Syed Hamza Sohail 09/21/2022 Leave a Comment

Naveris Raises $51M for Early Detection of Viral-Driven Cancers

What You Should Know: - Naveris, Inc., a commercial-stage life sciences company dedicated to improving patient care through earlier detection of viral-driven cancers, recently announced a $33.4M expansion of its Series A financing, bringing the total investment in Naveris to $51M. - The financing was led by Gurnet Point Capital, joined by TechU Ventures and BrightEdge, the impact and venture capital arm of the American Cancer Society. Using DNA Fragmentomics Technology to Detect
Read More

Pretzel Therapeutics Launches With $72.5M to Pioneer Mitochondrial Therapies

by Syed Hamza Sohail 09/20/2022 Leave a Comment

Pretzel Therapeutics Launches With $72.5M to Pioneer Mitochondrial Therapies

What You Should Know: - Pretzel Therapeutics, a biotechnology company harnessing the intricacies of mitochondrial biology to develop groundbreaking therapies, launched today with $72.5M in Series A financing to pioneer novel therapies to modulate mitochondrial function. - The financing was led by ARCH Venture Partners and Mubadala Capital with participating investors HealthCap, Cambridge Innovation Capital, Cambridge Enterprise, Angelini Ventures, GV, Invus, Eir Ventures, GU Ventures, and
Read More

Epic Launches Life Sciences Program with Clinical Trial Matchmaking

by Fred Pennic 09/16/2022 Leave a Comment

Epic Systems

What You Should Know: - Epic launches Life Sciences program, expanding its work to bring together the disconnected parts of healthcare. - The Epic Life Sciences program is built to help providers, pharmaceutical companies, and medical device manufacturers recruit research participants, expand clinical trial access to underrepresented communities, and speed up the development of new therapies. Unifying Clinical Research with Care Delivery Providers across the world use Epic to
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 50
  • Go to page 51
  • Go to page 52
  • Go to page 53
  • Go to page 54
  • Interim pages omitted …
  • Go to page 86
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Virta Health CEO: GLP-1s Didn’t Kill Weight Watchers, Its Broken Model Did

Most-Read

Moving Beyond EHRs: What Lies Ahead for Healthcare Digitization?

AI Agents vs. Chatbots: Understanding Agentic AI’s Role in Healthcare

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

AI Breakthrough Reveals 2025 AI Breakthrough Award Winners

Healthcare's Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Healthcare’s Big Blind Spot: The Measurement Crisis in Inpatient Psychiatry

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Lessons Learned from The Change Healthcare Cyberattack, One Year Later

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |